Skip to main content
. 2007 May;85(5):348–353. doi: 10.2471/06.035402

Annex 2. 78 countries that received anti-tuberculous drugs through the Stop TB Partnership’s Global Drug Facility, 2001–2007a.

1. Afghanistan 26. Ethiopia 51. Myanmar
2. Albania 27. Gabon 52. Namibia
3. Angola 28. Gambia 53. Nepal
4. Armenia 29. Georgia 54. Niger
5. Azerbaijan 30. Ghana 55. Nigeria
6. Bangladesh 31. Guinea 56. Pakistan
7. Benin 32. Guyana 57. Papua New Guinea
8. Bolivia 33. Haiti 58. Philippines
9. Bosnia and Herzegovina 34. India 59. Republic of Moldova
10. Burkina Faso 35. Indonesia 60. Rwanda
11. Burundi 36. Iraq 61. Sao Tome and Principe
12. Cambodia 37. Kenya 62. Serbia
13. Cameroon 38. Kyrgyzstan 63. Sierra Leone
14. Cape Verde 39. Lao People’s Democratic Republic 64. Somalia
15. Central African Republic 40. Lebanon 65. Sri Lanka
16. Chad 41. Lesotho 66. Sudan
17. Congo 42. Liberia 67. Syrian Arab Republic
18. Côte d’Ivoire 43. Madagascar 68. Tajikistan
19. Democratic People’s Republic of Korea 44. Malawi 69. The former Yugoslav Republic of Macedonia
20. Democratic Republic of the Congo 45. Maldives 70. Timor-Leste
21. Djibouti 46. Mali 71. Togo
22. Dominican Republic 47. Mauritania 72. Turkmenistan
23. Egypt 48. Micronesia, Federated States of 73. Uganda
24. Equatorial Guinea 49. Mongolia 74. Ukraine
25. Eritrea 50. Mozambique 75. United Republic of Tanzania
76. Uzbekistan
77. Yemen
78. Zambia

a The 15 countries highlighted in bold are among the 22 high-burden countries that account for 80% of the global burden of TB; 10 of these 15 countries are profiled in more detail in Annex 1.